Credit Suisse Maintains Neutral on Rambus, Raises Price Target to $25

Credit Suisse analyst John Pitzer maintains Rambus (NASDAQ:RMBS) with a Neutral and raises the price target from $22.5 to $25.

byBenzinga Newsdesk

November 2, 2021

1 minute read

Credit Suisse analyst John Pitzer maintains Rambus (NASDAQ:RMBS) with a Neutral and raises the price target from $22.5 to $25.

News

‘Apple Job Listings Suggest The Company Is Building A Metaverse Of Its Own For It Long-Rumored Headset’ – Business Insider

By Benzinga Newsdesk

Today, 5:36 AM

Job Listings Suggest Apple Is Building a Metaverse of Its Own (businessinsider.com) Apple is looking for engineers to build a 3D world for its yet-to-be-announced mixed-reality headset, Bloomberg first

AAPL

Here’s How To Watch The Tesla ‘Cyber Rodeo’ Today

By Chris Katje

Today, 5:36 AM

A highly anticipated event kicks off at Gigafactory Texas for Tesla Inc (NASDAQ: TSLA). The event will welcome thousands of people to see the factory and hear from CEO Elon Musk, and there's a way for people to watch the event from the comfort of their homes.

TSLA

IDMC Recommends Tonix Pharma To Stop Enrollment In Fibromyalgia Trial; Shares Drop

By Vandana Singh

Today, 5:36 AM

Following an unblinded, pre-planned interim analysis by the Independent Data Monitoring Committee (IDMC), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) will stop enrollment in the Phase 3 RALLY study of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for fibromyalgia.

TNXP

News

U.S. FTC Orders End To ‘Illegal’ Mastercard Business Tactics And Requires It To Stop ‘Blocking Competing Debit Card Payment Networks”

By Benzinga Newsdesk

Today, 5:36 AM

https://www.ftc.gov/news-events/news/press-releases/2022/12/ftc

Credit Suisse Maintains Neutral on Rambus, Raises Price Target to $25

Related Posts

‘Apple Job Listings Suggest The Company Is Building A Metaverse Of Its Own For It Long-Rumored Headset’ – Business Insider

Here’s How To Watch The Tesla ‘Cyber Rodeo’ Today

IDMC Recommends Tonix Pharma To Stop Enrollment In Fibromyalgia Trial; Shares Drop

U.S. FTC Orders End To ‘Illegal’ Mastercard Business Tactics And Requires It To Stop ‘Blocking Competing Debit Card Payment Networks”